Renal involvement in Waldenström’s macroglobulinemia: case report and review of literature

References

• Gnemmi V, Leleu X, Provot F, Moulonguet F, Buob D. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia. Am J Kidney Dis. 2012;60(3):487–491
   Google Scholar
• Gertz MA. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012;87(5):503–510
   PubMed Web of Science ®Google Scholar
• Isaac J, Herrera GA. Cast nephropathy in a case of Waldenström's macroglobulinemia. Nephron. 2002;91(3):512–515
   PubMed Web of Science ®Google Scholar
• Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenström's macroglobulinemia. Nephron. 2002;92(2):452–455
   Google Scholar
• Hory B, Saunier F, Wolff R, Saint-Hillier Y, Coulon G, Perol C. Waldenström macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron. 1987;45(1):68–70
   PubMed Web of Science ®Google Scholar
• Lindström FD, Hed J, Eneström S. Renal pathology of Waldenström's macroglobulinemia with monoclonal antiglomerular antibodies and nephrotic syndrome. Clin Exp Immunol. 1980;41(2):196–204
   PubMed Web of Science ®Google Scholar
• Terrier B, Buzyn A, Hummel A, et al. Serum monoclonal component and nephrotic syndrome -- it is not always amyloidosis. Diagnosis: WM complicated by retroperitoneal and renal infiltration and associated with a minimal change disease. Nephrol Dial Transplant. 2006;21(11):3327–3329
   Google Scholar
• Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. Acute tubular necrosis in a patient with Waldenström's macroglobulinemia and hyperviscosity syndrome. Nephrol Dial Transplant. 2000;15(10):1684–1687
   Google Scholar
• Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G. Pathology of the kidney in Waldenström's macroglobulinemia. Study of sixteen cases. N Engl J Med. 1970;283(3):123–129
   PubMedGoogle Scholar
• Martelo OJ, Schultz DR, Pardo V, Perez-stable E. Immunologically-mediated renal disease in Waldenström's macroglobulinemia. Am J Med. 1975;58(4):567–575
   PubMed Web of Science ®Google Scholar
• Meyrier A, Simon P, Mignon F, Striker L, Ramée MP. Rapidly progressive (‘crescentic') glomerulonephritis and monoclonal gammapathies. Nephron. 1984;38(3):156–162
   PubMed Web of Science ®Google Scholar
• Nakamoto Y, Imai H, Hamanaka S, Yoshida K, Akihama T, Miura AB. IgM monoclonal gammopathy accompanied by nodular glomerulosclerosis, urine-concentrating defect, and hyporeninemic hypoaldosteronism. Am J Nephrol. 1985;5(1):53–58
   Google Scholar
• Ogami Y, Takasugi M, Soejima M, et al. Waldenström's macroglobulinemia associated with amyloidosis and crescentic glomerulonephritis. Nephron. 1989;51(1):95–98
   Google Scholar
• Tsuji M, Ochiai S, Taka T, Hishitani Y, Nagareda T, Mori H. Nonamyloidotic nephrotic syndrome in Waldenström's macroglobulinemia. Nephron. 1990;54(2):176–178
   PubMed Web of Science ®Google Scholar
• González Anglada MI, González García J, del Arco A, Picazo ML, Quevedo E, Vázquez Rodríguez JJ. Waldenström's macroglobulinemia, cryoglobulinemia type I and membranous glomerulonephritis. Med Clin (Barc). 1991;97(14):539–541
   Google Scholar
• Veltman GA, van Veen S, Kluin-Nelemans JC, Bruijn JA, van Es LA. Renal disease in Waldenström's macroglobulinemia. Nephrol Dial Transplant. 1997;12(6):1256–1259
   PubMed Web of Science ®Google Scholar
• Soetekouw R, Bruijn JA, Hogewind BL, Bieger R. A 66-year-old woman with nephrotic syndrome and an IgM monoclonal gammopathy. Ann Hematol. 1998;76(5):227–230
   Google Scholar
• Dussol B, Kaplanski G, Daniel L, Brunet P, Pellissier JF, Berland Y. Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid. Nephrol Dial Transplant. 1998;13(10):2630–2632
   Google Scholar
• Harada Y, Ido N, Okada T, et al. Nephrotic syndrome caused by protein thrombi in glomerulocapillary lumen in Waldenström's macroglobulinemia. Br J Hematol. 2000;110(4):880–883
   Google Scholar
• Yonemura K, Suzuki T, Sano K, Fujigaki Y, Ikegaya N, Hishida A. A case with acute renal failure complicated by Waldenström's macroglobulinemia and cryoglobulinemia. Ren Fail. 2000;22(4):511–515
   PubMed Web of Science ®Google Scholar
• Da'as N, Polliack A, Cohen Y, et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Hematol. 2001;67(3):158–164
   PubMed Web of Science ®Google Scholar
• Garcia-Pacheco I, Khan A, Venkat KK. Rapidly progressive glomerulonephritis in a patient with Waldenström's macroglobulinemia. Clin Nephrol. 2005;64(5):396–399
   Google Scholar
• Audard V, Georges B, Vanhille P, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol. 2008;3(5):1339–1349
   PubMed Web of Science ®Google Scholar
• Colović N, Terzić T, Andelić B, et al. Nephrotic syndrome and acute renal failure in non-Hodgkin lymphoplasmacytic lymphoma. Med Oncol. 2008;25(4):458–461
   Google Scholar
• Kawano N, Ikeda N, Yoshida S, et al. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Int J Hematol. 2010;92(2):391–397
   Google Scholar
• Kim YL, Gong SJ, Hwang YH, et al. Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report. J Korean Med Sci. 2011;26(6):824–828
   Google Scholar
• Martina MN, Solé M, Massó E, Pérez N, Campistol JM, Quintana LF. Mixed cryoglobulinemia not related to hepatitis C virus, mesangiocapillary glomerulonephritis and lymphoplasmocytic lymphoma. Nefrologia. 2011;31(6):743–746
   Google Scholar
• Lee B, Smith RS, Tanphaichitr N, Novak R, Robertson S, Haller NA. Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy. Scand J Urol Nephrol. 2011;45(6):473–477
   PubMed Web of Science ®Google Scholar
• Pérez NS, Garcia-Herrera A, Rosiñol L, et al. Lymphoplasmacytic lymphoma causing light chain cast nephropathy. Nephrol Dial Transplant. 2012;27(1):450–453
   Google Scholar
• Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant. 2008;23(1):377–380
   Google Scholar
• Takei T, Nitta K. Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol. 2011;15(5):641–647
   Google Scholar
• Gilbert R, Hulse E, Rigden S. Rituximab therapy for steroid dependent minimal change nephrotic syndrome. Pediatr Nephrol. 2006;21:1698–1700
   PubMedGoogle Scholar